Read articles from Global
May 08, 2026 by news-medical.net
Smokers now view e-cigarettes as riskier after lung injury crisis
Public perceptions of e-cigarettes' risks have shifted due to factors like the EVALI scare. Although e-cigarettes were initially seen as less harmful than cigarettes, negative views have increased. A study analyzed data from a clinical trial of smokers using e-cigarettes, finding that perceptions of e-cigarette risk rose after EVALI. Even though e-cigarettes are generally considered less harmful, EVALI led to a temporary increase in perceived risk. The study suggests monitoring smokers' perceptions of e-cigarettes to guide future policies. Correcting misperceptions is vital to encourage smokers to transition to less harmful options. Recommendations include FDA-approved aids for smoking cessation over e-cigarettes.
May 08, 2026 by filtermag.org
Tobacco Harm Reduction Should Be Part of HIV Care
Around 41 million people globally live with HIV, with smoking rates among this group being significantly higher than national averages. In countries like Australia, Austria, Germany, and Italy, up to half of people with HIV smoke. The National Cancer Institute notes that smoking cessation is crucial for those with HIV, as it can impact life expectancy and increase the risk of smoking-related diseases. Interventions to quit smoking should be integrated into HIV care services, as seen in countries like Switzerland and the United States. Safer nicotine products may play a vital role in helping people with HIV quit smoking and improve their overall health outcomes.
May 08, 2026 by cbsnews.com
Fruit-flavored e-cigarettes for adults OK'd by FDA
FDA approved fruit-flavored e-cigarettes for adult smokers, marking a policy change following lobbying efforts on President Trump.
May 06, 2026 by thefirebreak.org
Michael Bloomberg’s MPOWER Empire
The influence of private funding on global public health policy is becoming an increasingly debated issue. Analysis highlights how large-scale philanthropic investment can shape not only funding priorities but also the direction of international health strategies. In the case of Michael Bloomberg, billions of dollars have been channelled into tobacco control initiatives through a network of interconnected organisations. This structure is argued to amplify a single policy perspective across multiple institutions, including programmes linked to the World Health Organization. Critics suggest that such influence may limit debate around harm reduction approaches and alternative nicotine products. The discussion raises broader questions about transparency, accountability and the role of private actors in shaping global health agendas.
May 06, 2026 by tobaccojournal.com
From harm reduction to protection
The debate around tobacco policy is increasingly shifting from harm reduction towards a more precautionary, protection-focused approach. While harm reduction strategies aim to lower risks for existing smokers, critics argue that newer policies place greater emphasis on preventing any nicotine use altogether. This shift reflects growing concern about addiction, youth uptake and the long-term societal impact of nicotine products. At the same time, it raises questions about whether moving away from harm reduction could limit options for smokers who are unable or unwilling to quit entirely. The discussion highlights a widening divide between approaches centred on individual risk reduction and those prioritising population-level prevention. Ultimately, the issue underscores the challenge of balancing public health protection with pragmatic strategies to reduce smoking-related harm.
May 05, 2026 by springer.com
A systematic review and meta-analysis of the association between e-cigarette use and cigarette abstinence or changes in continued cigarette smoking among individuals who smoke cigarettes - Harm Reduct
E-cigarettes are increasingly being examined for their role in smoking cessation and reduction. A systematic review and meta-analysis evaluates how nicotine-containing e-cigarettes influence quitting outcomes. The findings suggest a positive association between e-cigarette use and both smoking abstinence and reduced cigarette consumption over time. However, results vary depending on the type of comparison, with some analyses showing no significant difference when compared to traditional nicotine replacement therapies. Overall, the evidence points to a potential role for e-cigarettes in supporting smoking cessation, while highlighting the need for further long-term research.
May 05, 2026 by springer.com
A systematic review and meta-analysis of the association between e-cigarette use and cigarette abstinence or changes in continued cigarette smoking among individuals who smoke cigarettes
E-cigarettes are increasingly being examined for their role in smoking cessation and reduction. A systematic review and meta-analysis evaluates how nicotine-containing e-cigarettes influence quitting outcomes. The findings suggest a positive association between e-cigarette use and both smoking abstinence and reduced cigarette consumption over time. However, results vary depending on the type of comparison, with some analyses showing no significant difference when compared to traditional nicotine replacement therapies. Overall, the evidence points to a potential role for e-cigarettes in supporting smoking cessation, while highlighting the need for further long-term research.
May 05, 2026 by substack.com
B.I.G. Big Tobacco, Big Vape, Big Nicotine — and the People Erased by Big Language Part II
Language in the nicotine debate is shaping how entire issues—and the people within them—are understood. Expanding labels like “Big Tobacco”, “Big Vape” and “Big Nicotine” can blur important distinctions between products, risks and behaviours. This framing risks shifting focus away from the core issue: reducing harm from smoking. It may also overlook the experiences of adults who use alternatives or are trying to move away from cigarettes. By broadening the narrative, policy discussions can unintentionally erase the very people they aim to protect. Ultimately, the debate raises questions about whether public health messaging is clarifying reality or oversimplifying it.
May 05, 2026 by substack.com
B.I.G. Big Business — When the Past Screams at the Future Part I
The idea of “Big” in the nicotine debate—whether referring to large industries or powerful interests—is often used to simplify a highly complex issue. Such framing can shift attention away from the real experiences of individuals who use these products. Focusing only on major players risks overlooking the role of harm reduction for people trying to move away from smoking. It also shapes public perception in ways that may not fully reflect reality. A more balanced perspective would place greater emphasis on individual outcomes rather than labels and narratives.
May 04, 2026 by clearingtheair.eu
Smoke-free by 2040 within reach – but only with wider access to safer nicotine alternatives
Reaching a smoke-free target by 2040 is increasingly viewed as possible, but current strategies may not be sufficient on their own. Progress in reducing smoking rates appears to be slowing, particularly among more dependent and vulnerable populations. Expanding access to regulated smoke-free nicotine alternatives—such as vapes, heated tobacco and nicotine pouches—could help accelerate this decline. Experiences from countries like Sweden, Japan and New Zealand suggest that wider availability of these products is linked to faster reductions in smoking. Achieving long-term public health goals may therefore depend on a more balanced, risk-proportionate approach that supports switching alongside prevention.